Rockwell Medical Inc (RMTI)
1.52
+0.02
(+1.33%)
USD |
NASDAQ |
Apr 23, 16:00
1.52
0.00 (0.00%)
After-Hours: 18:51
Rockwell Medical Cash from Investing (TTM): -3.045M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -3.045M |
September 30, 2023 | -1.835M |
June 30, 2023 | -6.24M |
March 31, 2023 | -6.227M |
December 31, 2022 | -2.396M |
September 30, 2022 | -5.074M |
June 30, 2022 | 8.258M |
March 31, 2022 | 9.956M |
December 31, 2021 | 0.311M |
September 30, 2021 | 0.408M |
June 30, 2021 | 3.647M |
March 31, 2021 | 0.114M |
December 31, 2020 | 3.212M |
September 30, 2020 | 2.747M |
June 30, 2020 | -0.2692M |
March 31, 2020 | -5.741M |
December 31, 2019 | -4.75M |
September 30, 2019 | -2.722M |
June 30, 2019 | 5.745M |
March 31, 2019 | 16.82M |
December 31, 2018 | 12.72M |
September 30, 2018 | 19.84M |
June 30, 2018 | 12.01M |
March 31, 2018 | 14.11M |
December 31, 2017 | 14.50M |
Date | Value |
---|---|
September 30, 2017 | 2.531M |
June 30, 2017 | 5.203M |
March 31, 2017 | -1.572M |
December 31, 2016 | -1.644M |
September 30, 2016 | 0.5274M |
June 30, 2016 | -1.797M |
March 31, 2016 | -21.27M |
December 31, 2015 | -21.14M |
September 30, 2015 | -31.83M |
June 30, 2015 | -31.86M |
March 31, 2015 | -6.552M |
December 31, 2014 | -8.809M |
September 30, 2014 | 0.2032M |
June 30, 2014 | -9.796M |
March 31, 2014 | -14.83M |
December 31, 2013 | -12.65M |
September 30, 2013 | -0.0286M |
June 30, 2013 | 13.45M |
March 31, 2013 | 11.46M |
December 31, 2012 | 11.52M |
September 30, 2012 | 0.982M |
June 30, 2012 | -2.459M |
March 31, 2012 | -0.4734M |
December 31, 2011 | -0.5879M |
September 30, 2011 | -12.75M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-6.24M
Minimum
Jun 2023
9.956M
Maximum
Mar 2022
-0.2053M
Average
-0.2692M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
Cyclacel Pharmaceuticals Inc | -0.006M |
Oragenics Inc | -0.9363M |
Alpine Immune Sciences Inc | -55.56M |
Corvus Pharmaceuticals Inc | 15.54M |
MAIA Biotechnology Inc | -- |